Related Experiment Videos
Celiac plexus block in cancer pain management
1Department of Anesthesiology and Emergency Medicine, Tohoku University Postgraduate Medical School, Sendai, Japan. y-0910@mail.cc.tohoku.ac.jp
The Tohoku Journal of Experimental Medicine
|December 29, 2000
Summary
Neurolytic celiac plexus block (NCPB) offers effective pain relief for upper abdominal cancer. This procedure provides significant quality of life improvement with manageable side effects.
Area of Science:
- Pain Management
- Interventional Oncology
- Gastroenterology
Background:
- The World Health Organization recommends neurolytic celiac plexus block (NCPB) for managing upper abdominal cancer pain.
- Current indications for NCPB lack well-validated criteria, necessitating comprehensive pain assessment.
Purpose of the Study:
- To review the indications, techniques, and adverse effects of NCPB.
- To evaluate the efficacy and safety of NCPB based on literature and clinical experience.
Main Methods:
- Review of existing literature on NCPB.
- Analysis of 142 NCPB procedures performed over 11 years.
- Utilized the retrocrural transdiscal approach for its simplicity and safety.
Main Results:
- No significant difference in pain relief efficacy among various NCPB techniques.
- Adverse effects such as pain, hypotension, and diarrhea are generally transient and controllable.
- Diarrhea may offer a benefit by counteracting opioid-induced constipation.
Conclusions:
- NCPB is an effective treatment for visceral pain in upper abdominal cancer with a favorable safety profile.
- The procedure can significantly improve the quality of life for patients experiencing abdominal cancer pain.
- The term "peri-aortic nerve block" may more accurately describe the intervention.